Support Line: 0800 002 9002
General Enquiries: 01223 870008
  »  Kidney Cancer News  »  Surgeons use balloon in robotic surgery on kidney tumor

Surgeons use balloon in robotic surgery on kidney tumor

by | May 29, 2015 | Kidney Cancer News

Story from USCNews in USA.

Aimed at decreasing blood loss, the procedure could lessen the length of surgery by two hours

Kidney cancer is among the 10 most common cancers in the United States. (Illustration/Gray’s Anatomy, Plate 1120)
A procedure intended to decrease blood loss during removal of a kidney tumor that had grown into a major vein via robotic surgery was recently performed successfully for the first time at Keck Medicine of USC. The procedure has the potential to decrease the length of surgery from five hours to three hours.
Using a 3-centimeter balloon to block blood flow during the surgery, a team of surgeons led by Inderbir Gill, executive founder of the USC Institute of Urology, isolated a 6-centimeter tumor growing into the inferior vena cava (IVC), a critical vein bringing deoxygenated blood from the legs to the heart. The balloon cut off blood flow within the vessel while the tumor was removed and minimized the amount of blood loss during the operation. The tumor posed specific challenges solved by the balloon, Gill said.
“About 10 to 15 percent of kidney cancer patients are diagnosed with an IVC tumor thrombus, which is a tumor that grows into the inferior vena cava,” Gill said. “In this case, the tumor was attached to the patient’s liver by many small blood vessels. This required us to control the vessels delicately, which we could do more safely with the balloon than with standard clamping and without the need to separate the vena cava from the liver.”
The intra-IVC balloon was used to isolate the tumor thrombus in the part of the IVC close to the heart, at a section where the liver was attached to the vena cava. A clamp controlled the blood flow at the end toward the patient’s legs. Gill said the balloon would have applications for other types of robotic and IVC thrombectomy surgery. Patient Nestor Martinez of Bakersfield was discharged the day after surgery, Gill said.

Read the full story here

<a href="https://www.kcuk.org.uk/author/mp/" target="_self">Malcolm Packer</a>

Malcolm Packer

Malcolm is Chief Executive Officer at Kidney Cancer UK and Kidney Cancer Scotland and has worked with the charity in various capacities for over 15 years.